Efficacy and Safety of Fruquintinib in Combination With Sintilimab in Advanced Renal Cell Carcinoma (FRUSICA-2)
Clinical trial NCT05522231 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05522231
- Sponsor
- Hutchmed
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-27
- Primary completion
- 2025-01-01
- Enrollment
- 265
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.